3507 results for «2035»
3507 results
Transforming patient access and care for valvular heart disease
17 Nov 2019 – From PCR London Valves 2019
Consult this session on valvular heart disease to learn about the current and future patient transcatheter treatment options and the future challenges they bring for the heart teams, and discover the importance of valve design choice for the patient's future.
TAVI: stroke, cerebral protection and alternative vascular access
18 Nov 2019 – From PCR London Valves 2019
Consult this session to discover the results of various TAVI trials and studies, and learn more about stroke, cerebral embolic protection and alternative vascular access.
Shockwave IVL: a new alternative to alternative TAVI access
18 Nov 2019 – From PCR London Valves 2019
Consult this session to learn about new options for alternative TAVI access to cope with most challenges, as well as various approaches to patient selection. Gain insight also into how intravascular lithotripsy may be an option to preserve transfemoral TAVI, with a selection of clinical cases and...
TAVI complications and challenging vascular access
18 Nov 2019 – From PCR London Valves 2019
Increasing safety in complex TAVI procedures
18 Nov 2019 – From PCR London Valves 2019
Consult this session to review the current data on cerebral embolic protection during TAVI, to learn about different options for complex TAVI procedures and to discover future options for transcatheter mitral valve repair, thanks to a selection of various studies and challenging clinical cases.
Spotlight - Challenges for the Heart Team I - A new interventional paradigm for aortic valve disease
18 Nov 2019 – From PCR London Valves 2019
Consult this session on aortic valve disease to learn more about the impact of the latest evidence concerning TAVI vs. SAVR on Heart Team discussions and patient choice (clinical and anatomical characteristics, redistribution of resources and training...), and discover how you and your colleagues can apply this information in...
TAVI: predicting the need for permanent pacing
18 Nov 2019 – From PCR London Valves 2019
Consult this session to learn more about how to predict the need for permanent pacemaker implantation after TAVI, thanks to a selection of studies regarding novel anatomic predictors, newer MDCT measurements, and more!
Innovations in TAVI technique and technology to address evolving patient needs
18 Nov 2019 – From PCR London Valves 2019
Consult this session to learn all about the innovations in TAVI technique and technology, adapting to the changing needs of younger and lower risk patients, and discover how to optimise TAVI procedural outcomes and minimise the need for permanent pacemaker implantation and how to use Evolut PRO+ valve...
A team approach to the management of tricuspid regurgitation
Consult this session to learn all about tricuspid valve disease: anatomy, imaging, guideline-directed treatment, and discover new transcatheter treatment options for tricuspid regurgitation, as well as the specific advantages of the Edwards Cardioband tricuspid valve reconstruction system for your patients.
Challenging clinical scenarios in valve interventions - Hosted by Germany, Spain and Singapore
18 Nov 2019 – From PCR London Valves 2019
Consult this session to discover various challenging clinical cases and complications in valve interventions, such as MitraClip for cardiogenic shock, repositionning of a dislodged ALLEGRA transcatheter aortic valve, delayed coronary obstruction, percutaneous closure of a posterior leaflet perforation, and more!
New perspectives – Treatment of secondary mitral regurgitation in patients with heart failure
18 Nov 2019 – From PCR London Valves 2019
Consult this session on the treatment of secondary mitral regurgitation in patients with heart failure to learn more about how to implant the Carillon Mitral Contour System, and what is the impact of cinching the mitral apparatus on regurgitant volume and left ventricular remodeling.
Improving patient access and clinical outcomes in the treatment of aortic stenosis - The Edwards Benchmark Program
18 Nov 2019 – From PCR London Valves 2019
Consult this session to learn more about the current and future constraints on aortic stenosis treatment in Europe, and gain insight into the Edwards Benchmark Program, aiming to optimize patient outcomes, care pathway and efficiency.
Heart Team 2.0 in action: how to manage complex TAVI procedures
18 Nov 2019 – From PCR London Valves 2019
Consult this session to learn how to plan a successful TAVI procedure for your patients with challenging anatomy and high-risk clinical characteristics, such as: with a bicuspid aortic valve and associated aortopathy, with severe LVOT calcification, with a high risk of left main coronary occlusion, and more!
Will PARTNER-3 and Evolut low-risk trials change my practice?
18 Nov 2019 – From PCR London Valves 2019
Consult this session to learn all about PARTNER-3 and Evolut trials, and gain an in-depth understanding of these trials comparing TAVI and SAVR in patients at low surgical risk, while appreciating their limitations and key remaining questions.
Innovations in transcatheter tricuspid valve intervention
18 Nov 2019 – From PCR London Valves 2019
Consult this session to learn all about the innovations in transcatheter tricuspid valve intervention: discover the new transcatheter treatment strategies, improve your understanding of the clinical indications for intervention, and appreciate the challenges and limitations of tricuspid valve imaging before and during the intervention.
Long-term clinical outcomes after SAVR and TAVI
19 Nov 2019 – From PCR London Valves 2019
Consult this session to learn all about the long-term clinical outcomes after SAVR and TAVI, thanks to a variety of studies and registries: BIVOLUT-X, STS/ACC TVT, and more!
Case-based learning for the Heart Team: patient selection for tricuspid valve interventions
18 Nov 2019 – From PCR London Valves 2019
Consult this session on patient selection for tricuspid valve interventions to gain insights into how clinical and anatomical characteristics influence patient and device selection, and to become more familiar with the key steps in transcatheter tricuspid valve procedures.
Controversy - Challenges for the Heart Team II - Mitral regurgitation and heart failure - Where two worlds meet
19 Nov 2019 – From PCR London Valves 2019
Consult this session on mitral regurgitation and heart failure to hear the latest thinking concerning the optimal management of patients suffering from these diseases, and discover the implications of recent trials for your clinical practice, such as COAPT, MITRA-FR, and more!
TAVI: management of unusual complications
19 Nov 2019 – From PCR London Valves 2019
Consult this session to learn more about how to manage the following unusual TAVI complications: wire entrapment in hypertrabecular left ventricle after aortic valve release, iatrogenic VSD after TAVI in a patient with bicuspid severe aortic stenosis, ruptured pseudoaneurysm of the mitral-aortic intervalvular fibrosa, unsuccessful TAVI in...
Heart Team 2.0 in action: TAVI or SAVR in younger lower-risk patients?
18 Nov 2019 – From PCR London Valves 2019
Consult this session on TAVI vs SAVR in younger lower-risk patients to learn all about the outcomes of various recent trials and how to translate them into your clinical practice, thanks to a selection of challenging cases involving bicuspid aortic valve disease, small aortic annulus, and complex...
